View in EDS

Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial.

Saved in:
Bibliographic Details
Title: Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial.
Authors: Wijsenbeek MS; Center of Expertise for Interstitial Lung Diseases, Department of Respiratory Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands m.wijsenbeek-lourens@erasmusmc.nl., Assassi S; Division of Rheumatology, McGovern Medical School, UTHealth Houston, Houston, TX, USA., Azuma A; Clinical Research Center, Mihara General Hospital, Saitama, Japan.; Nippon Medical School, Tokyo, Japan., Cottin V; National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, UMR 754, ERN-LUNG, Lyon, France., Hoffmann-Vold AM; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Maher TM; Department of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK., Martinez FJ; University of Massachusetts (UMass) Chan Medical School/UMass Memorial Health System, Worcester, MA, USA., Oldham JM; Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA., Richeldi L; Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy., Valenzuela C; Pulmonology Department, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain., Gu H; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Ritter I; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Stowasser S; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany., Kreuter M; Center for Pulmonary Medicine, Department of Pneumology, Mainz University Medical Center and Pulmonary, Critical Care and Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany.
Corporate Authors: FIBRONEER-ILD Trial Investigators
Source: The European respiratory journal [Eur Respir J] 2026 Jul 09; Vol. 68 (1). Date of Electronic Publication: 2026 Jul 09 (Print Publication: 2026).
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41887669
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wijsenbeek+MS%22">Wijsenbeek MS</searchLink>; Center of Expertise for Interstitial Lung Diseases, Department of Respiratory Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands m.wijsenbeek-lourens@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22Assassi+S%22">Assassi S</searchLink>; Division of Rheumatology, McGovern Medical School, UTHealth Houston, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Azuma+A%22">Azuma A</searchLink>; Clinical Research Center, Mihara General Hospital, Saitama, Japan.; Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Cottin+V%22">Cottin V</searchLink>; National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, UMR 754, ERN-LUNG, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Hoffmann-Vold+AM%22">Hoffmann-Vold AM</searchLink>; Department of Rheumatology, Oslo University Hospital, Oslo, Norway.; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Maher+TM%22">Maher TM</searchLink>; Department of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Section of Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Martinez+FJ%22">Martinez FJ</searchLink>; University of Massachusetts (UMass) Chan Medical School/UMass Memorial Health System, Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Oldham+JM%22">Oldham JM</searchLink>; Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Richeldi+L%22">Richeldi L</searchLink>; Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Valenzuela+C%22">Valenzuela C</searchLink>; Pulmonology Department, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gu+H%22">Gu H</searchLink>; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Ritter+I%22">Ritter I</searchLink>; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Stowasser+S%22">Stowasser S</searchLink>; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Kreuter+M%22">Kreuter M</searchLink>; Center for Pulmonary Medicine, Department of Pneumology, Mainz University Medical Center and Pulmonary, Critical Care and Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22FIBRONEER-ILD+Trial+Investigators%22">FIBRONEER-ILD Trial Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228803460%22">The European respiratory journal</searchLink> [Eur Respir J] 2026 Jul 09; Vol. 68 (1). <i>Date of Electronic Publication: </i>2026 Jul 09 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Respiratory+Society%22">European Respiratory Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8803460 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1399-3003 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209031936%22">09031936 </searchLink><i>NLM ISO Abbreviation: </i>Eur Respir J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41887669
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1183/13993003.01899-2025
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wijsenbeek MS
      – PersonEntity:
          Name:
            NameFull: Assassi S
      – PersonEntity:
          Name:
            NameFull: Azuma A
      – PersonEntity:
          Name:
            NameFull: Cottin V
      – PersonEntity:
          Name:
            NameFull: Hoffmann-Vold AM
      – PersonEntity:
          Name:
            NameFull: Maher TM
      – PersonEntity:
          Name:
            NameFull: Martinez FJ
      – PersonEntity:
          Name:
            NameFull: Oldham JM
      – PersonEntity:
          Name:
            NameFull: Richeldi L
      – PersonEntity:
          Name:
            NameFull: Valenzuela C
      – PersonEntity:
          Name:
            NameFull: Gu H
      – PersonEntity:
          Name:
            NameFull: Ritter I
      – PersonEntity:
          Name:
            NameFull: Stowasser S
      – PersonEntity:
          Name:
            NameFull: Kreuter M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 07
              Text: 2026 Jul 09
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1399-3003
          Numbering:
            – Type: volume
              Value: 68
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The European respiratory journal
              Type: main
ResultId 1